locally advanced rectal cancer
Showing 1 - 25 of >10,000
Locally Advanced Rectal Cancer Trial in Guangzhou (AK104, Capecitabine, Neoadjuvant Radiotherapy)
Not yet recruiting
- Locally Advanced Rectal Cancer
- AK104
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 5, 2023
Locally Advanced Rectal Cancer, Total Neoadjuvant Treatment, Anti-PD-1 Trial in Changchun (nCRT ? (CapeOX+Sintilimab)×6 ?
Not yet recruiting
- Locally Advanced Rectal Cancer
- +2 more
- nCRT → (CapeOX+Sintilimab)×6 → Surgery/W&W
-
Changchun, Ji Lin, ChinaFirst Hospital of Jilin University
Aug 11, 2023
Rectal Tumors Trial in Nanning (Tislelizumab, Capecitabine, Oxaliplatin)
Recruiting
- Rectal Neoplasms
- Tislelizumab
- +4 more
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Aug 27, 2023
Rectal Cancer, Self Efficacy Trial in Boston (PATHWAYS, Enhanced usual care)
Not yet recruiting
- Rectal Cancer
- Self Efficacy
- PATHWAYS
- Enhanced usual care
-
Boston, MassachusettsMassachusetts General Hospital
Jun 22, 2023
MSS, Rectal Cancer Trial (Sintilimab with Interleukin-2)
Not yet recruiting
- MSS
- Rectal Cancer
- Sintilimab with Interleukin-2
- (no location specified)
Nov 1, 2023
Rectal Cancer Trial (Ketogenic Diet, Standard Diet)
Not yet recruiting
- Rectal Cancer
- Ketogenic Diet
- Standard Diet
- (no location specified)
Jul 3, 2023
Rectal Cancer Trial (CapeOX + cetuximab, CapeOX + bevacizumab, radiotherapy)
Not yet recruiting
- Rectal Cancer
- CapeOX + cetuximab
- +2 more
- (no location specified)
Sep 12, 2023
Rectal Cancer Trial in Chengdu (drug, radiation, procedure)
Recruiting
- Rectal Cancer
- Fruquintinib
- +3 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Mar 8, 2023
The Neutrophil To Lymphocyte Ratio In Locally Advanced Rectal
Not yet recruiting
- the Prognostic Value of Pre-treatment NLR in Patients With Locally Advenced Rectal Cancer and Post-treatment
- (no location specified)
Jan 4, 2023
Rectal Cancer, Locally Advanced Trial in Tunis (Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan),
Active, not recruiting
- Rectal Cancer
- Locally Advanced
- Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan)
- Radiotherapy
-
Tunis, TunisiaAmel Mezlini
May 19, 2023
Rectal Cancer Trial (Trifluridine/Tipiracil, intensity-modulated radiotherapy)
Not yet recruiting
- Rectal Cancer
- Trifluridine/Tipiracil
- intensity-modulated radiotherapy
- (no location specified)
Jul 27, 2023
Tumors, Rectal Trial (Dostarlimab)
Not yet recruiting
- Neoplasms, Rectal
- Dostarlimab
- (no location specified)
Feb 2, 2023
Locally Advanced Rectal Cancer Trial in Miami (Intensity-modulated radiation therapy, 5-fluorouracil, Leucovorin)
Recruiting
- Locally Advanced Rectal Cancer
- Intensity-modulated radiation therapy
- +5 more
-
Miami, FloridaUniversity of Miami
Oct 28, 2022
Locally Advanced Rectal Cancer, Locally Recurrent Rectal Cancer Trial in Southampton (Intraoperative Electron Radiotherapy
Recruiting
- Locally Advanced Rectal Cancer
- Locally Recurrent Rectal Cancer
- Intraoperative Electron Radiotherapy (IOERT)
- Extended Margin Surgery
-
Southampton, Hampshire, United KingdomUniversity Hospital Southampton NHS Foundation Trust
May 24, 2023
Locally Advanced Rectal Carcinoma Trial (Cadonilimab Injection, Short-course radiotherapy, Consolidation chemo)
Not yet recruiting
- Locally Advanced Rectal Carcinoma
- Cadonilimab Injection
- +2 more
- (no location specified)
Mar 19, 2023
Locally Advanced Rectal Carcinoma Trial in Cairo (short course radiation therapy followed by 6 cycles of CAPOX then surgery)
Completed
- Locally Advanced Rectal Carcinoma
- short course radiation therapy followed by 6 cycles of CAPOX then surgery
-
Cairo, الجيزة, EgyptNational Cancer Institute
Nov 11, 2022
Colorectal Cancer Stage II, Colorectal Cancer Stage III, Mmr Deficiency Trial in Guangzhou (drug, radiation, procedure, other)
Active, not recruiting
- Colorectal Cancer Stage II
- Colorectal Cancer Stage III
- Oxaliplatin
- +5 more
-
Guangzhou, Guangdong, ChinaMedical Oncology,Sun Yat-sen University Cancer Center
Jan 29, 2023
Locally Advanced Rectal Cancer Trial in Beijing (capecitabine, tislelizumab, thymalfasin)
Not yet recruiting
- Locally Advanced Rectal Cancer
- capecitabine
- +3 more
-
Beijing, China
- +1 more
Sep 21, 2023
Advanced Rectal Cancer Trial in Guangzhou (XELOX, Capecitabine monotherapy, Radiation)
Not yet recruiting
- Advanced Rectal Cancer
- XELOX
- +2 more
-
Guangzhou, Guangdong, ChinaZhenhai Lu
Oct 25, 2022
Locally Advanced Rectal Cancer Trial in Shijiazhuang (Tislelizumab, Short-course radiotherapy, Capecitabine+Oxaliplatin)
Recruiting
- Locally Advanced Rectal Cancer
- Tislelizumab
- +2 more
-
Shijiazhuang, Hebei, ChinaFourth Hospital of Hebei Medical University
Aug 1, 2022
MRI Criterion After Neoadjuvant Therapy in Locally Advanced
Completed
- Rectal Neoplasms
-
Nîmes, Gard, FranceChu de Nîmes
Sep 8, 2022
Locally Advanced Rectal Cancer Trial (AK104 injection, TME surgery, Capecitabine)
Not yet recruiting
- Locally Advanced Rectal Cancer
- AK104 injection
- +3 more
- (no location specified)
Apr 4, 2023
Locally Advanced Rectal Cancer, Older People Trial in Belgium (radiation, drug, procedure, combination product)
Not yet recruiting
- Locally Advanced Rectal Cancer
- Older People
- Short course radiotherapy
- +3 more
-
Edegem, Antwerpen, Belgium
- +12 more
Sep 18, 2023
Locally Advanced Rectal Carcinoma, Circulating Tumor DNA Trial in Beijing (circulating tumor DNA)
Recruiting
- Locally Advanced Rectal Carcinoma
- Circulating Tumor DNA
- circulating tumor DNA
-
Beijing, Beijing, ChinaDepartment of General Surgery, Peking Union Medical College Hosp
Oct 27, 2022